Title:
【発明の名称】AT1受容体のペプチド、及び子癇前症、悪性高血圧症におけるその使用
Document Type and Number:
Japanese Patent JP2002539075
Kind Code:
A
Abstract:
The invention relates to peptides of the AT1 receptor and their use for eliminating specifically binding, cell-physiologically active, pathological antibodies in preeclampsia. The inventive peptides are further used for the diagnosis of preeclampsia. According to the invention, peptides having the sequence AFHYESQ, AVHYQSN, SHFYQTR, GYYFDTN or ENTNIT are preferred.
Inventors:
Varkat, Geld
Homs, Volker
Luft, Friedrich
Homs, Volker
Luft, Friedrich
Application Number:
JP2000591065A
Publication Date:
November 19, 2002
Filing Date:
December 22, 1999
Export Citation:
Assignee:
Max-Dell Brook-Centrum Fur Moreclere Medizin
International Classes:
G01N33/53; A61K38/00; A61K39/00; A61M1/36; A61P9/12; A61P15/06; A61P43/00; C07K14/705; C07K16/28; A61K38/095; (IPC1-7): C07K14/705; A61K38/00; A61M1/36; A61P9/12; A61P15/06; A61P43/00; C07K16/28; G01N33/53
Attorney, Agent or Firm:
Yusuke Hiraki (2 outside)